Edgestream Partners, L.P. Repligen Corp Transaction History

Edgestream Partners, L.P.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$120.0 - $182.95 $293,400 - $447,312	2,445 New	2,445 $308,000
Q1 2023 May 15, 2023	SELL	$154.26 - $198.1 $1.18 Million - $1.52 Million	-7,681 Reduced 75.59%	2,480 $417,000
Q4 2022 Feb 13, 2023	BUY	$162.42 - $220.56 $104,436 - $141,820	643 Added 6.76%	10,161 $1.72 Million
Q3 2022 Nov 14, 2022	SELL	$160.42 - $256.21 $2.43 Million - $3.88 Million	-15,147 Reduced 61.41%	9,518 $1.78 Million
Q2 2022 Aug 12, 2022	BUY	$140.68 - $188.02 $404,314 - $540,369	2,874 Added 13.19%	24,665 $4.01 Million
Q1 2022 May 13, 2022	SELL	$161.19 - $257.96 $590,277 - $944,649	-3,662 Reduced 14.39%	21,791 $4.1 Million
Q4 2021 Feb 15, 2022	BUY	$247.59 - $304.47 $683,843 - $840,946	2,762 Added 12.17%	25,453 $6.74 Million
Q3 2021 Nov 15, 2021	BUY	$194.77 - $324.21 $1.9 Million - $3.17 Million	9,770 Added 75.61%	22,691 $6.56 Million
Q2 2021 Aug 10, 2021	BUY	$165.87 - $220.95 $2.14 Million - $2.85 Million	12,921 New	12,921 $2.58 Million

488

54.2M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $7.98B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Edgestream Partners, L.P., based on Form 13F filings with the SEC.

Stay updated on Edgestream Partners, L.P. with notifications on news.